IRIS Registry: Intelligent Research in Sight Registry
RecruitingObservational study
Who can join
6 Months · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients who meet the denominator requirements for each measure. Exclusion Criteria: * None
About the study
The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.
What is being tested
- Ophthalmology (procedure)
Sponsor: American Academy of Ophthalmology · Participants: 20,000,000 · Started: 2014-03
Contact the study team
- Andy Khuong · Phone: 415-561-8500
- Flora Lum, MD · Phone: 415-561-8500
Official record on ClinicalTrials.gov — NCT02485847
Locations in the U.S.
| California | American Academy of Opthalmology, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.